Form 4 for EW Edwards Lifesciences
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-03 · accession 0001225208-23-005433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-04 | 2023-05-03+ | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $87.96 | -75 | 169.1K | -0.0% | -$6,597 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-04 | F | D | 38 | $88.10 | 169,062.78 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-03 | F | D | 37 | $87.81 | 169,100.78 | D | — | — |